Community hospitals conducting hemithyroidectomy in Singapore achieve satisfactory disease control and excellent survival for minimally invasive follicular thyroid carcinoma (MIFTC), according to a recent study, adding that total thyroidectomy should be reserved for widely invasive (WI)FTC or aggressive tumours with nodal or distant metastasis.
Use of zoledronic acid for 2 years appears to be effective against cancer treatment-induced bone loss in premenopausal women with breast cancer, with bone mass density values maintained for up to 3 years after cessation of treatment, according to the results of the placebo-controlled ProBone II trial.
Hepatitis C virus (HCV) treatment may benefit patients with HCV-related hepatocellular carcinoma (HCC) who respond to the initial HCC palliative treatment, suggest the results of a study, adding, however, that treating HCV in HCC patient undergoing noncurative HCC treatment remains debatable.
A dual-hormone artificial pancreas (DAP) with a rapid delivery of insulin and pramlintide in a fixed ratio improves glycaemic control and reduces glucose variability in adults with type 1 diabetes (T1D) compared with first-generation artificial pancreas delivering insulin alone, according to a study presented at ADA 2018.
More intensive lowering of LDL-C levels was associated with a progressively greater survival benefit than less intensive approach, when the baseline LDL-C levels were ≥100 mg/dL, reveals a meta-analysis of 34 randomized trials.